Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by QualityTeston Oct 08, 2020 1:46pm
191 Views
Post# 31689663

RE:RE:RE:RE:RE:RE:RE:RE:Wtf

RE:RE:RE:RE:RE:RE:RE:RE:WtfWhere to begin with this..

I'm invested and I think my post history makes that clear. I've been invested since before topline failure last year and have continued to add to my position since then, with my last purchase being roighly a month ago. Last time I checked, I was down approx 55-60%. 

Again, you're bringing up his comment about seeing a deal before year end and It's October 8th... 
This is the first time, afaik, that DM has publicly stated a date that we would see a deal done by. If there isn't a deal done by Dec. 31, I'll borrow one of your pitchforks and join you in storming the castle. Until then, I'll let DM work on getting a deal done.

I see that you seem to be taking anonymous rumours that you read on the internet as gospel, and then (once again) becoming irate when they don't turn out to be true. You've done this before with someone's guess of $8 share price by August... does this really seem like solid DD to you? 

You stated that everything you wrote was 'fact'. I don't know how you are considering a "whispering" campaign about possibly having 2 BTDs as a "fact". 

You rant weekly(?) about this company yet continue to stay invested and even purchase more. You're responsible for your investing decisions. Investing in junior biotechs is risky... if that disturbs you as much as your posts suggest it does, putting more money in may not be the best idea. 

But glad to see that no one here is losing their minds. 

"...jmo"
<< Previous
Bullboard Posts
Next >>